Literature DB >> 15860482

Driving cessation and increased depressive symptoms.

David R Ragland1, William A Satariano, Kara E MacLeod.   

Abstract

BACKGROUND: To understand the consequences of driving cessation in older adults, the authors evaluated depression in former drivers compared with active drivers.
METHODS: Depression (as assessed using the Center for Epidemiological Studies Depression Scale), driving status, sociodemographic factors, health status, and cognitive function were evaluated for a cohort of 1953 residents of Sonoma County, California, aged 55 years and older, as part of a community-based study of aging and physical performance. The authors re-interviewed 1772 participants who were active drivers at baseline 3 years later.
RESULTS: At baseline, former drivers reported higher levels of depression than did active drivers even after the authors controlled for age, sex, education, health, and marital status. In a longitudinal analysis, drivers who stopped driving during the 3-year interval (i.e., former drivers) reported higher levels of depressive symptoms than did those who remained active drivers, after the authors controlled for changes in health status and cognitive function. Increased depression for former drivers was substantially higher in men than in women.
CONCLUSIONS: With increasing age, many older adults reduce and then stop driving. Increased depression may be among the consequences associated with driving reduction or cessation.

Entities:  

Mesh:

Year:  2005        PMID: 15860482     DOI: 10.1093/gerona/60.3.399

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  100 in total

Review 1.  Mobility and aging: new directions for public health action.

Authors:  William A Satariano; Jack M Guralnik; Richard J Jackson; Richard A Marottoli; Elizabeth A Phelan; Thomas R Prohaska
Journal:  Am J Public Health       Date:  2012-06-14       Impact factor: 9.308

Review 2.  Vision and driving.

Authors:  Cynthia Owsley; Gerald McGwin
Journal:  Vision Res       Date:  2010-05-23       Impact factor: 1.886

3.  The Impact of Health Problems on Driving Status among Older Adults.

Authors:  Kara E MacLeod; William A Satariano; David R Ragland
Journal:  J Transp Health       Date:  2014-06

4.  The longitudinal impact of cognitive speed of processing training on driving mobility.

Authors:  Jerri D Edwards; Charlsie Myers; Lesley A Ross; Daniel L Roenker; Gayla M Cissell; Alexis M McLaughlin; Karlene K Ball
Journal:  Gerontologist       Date:  2009-06-02

5.  Association of visual sensory function and higher-order visual processing skills with incident driving cessation.

Authors:  Carrie Huisingh; Gerald McGwin; Cynthia Owsley
Journal:  Clin Exp Optom       Date:  2016-06-28       Impact factor: 2.742

6.  Depression and Alzheimer's Disease Biomarkers Predict Driving Decline.

Authors:  Ganesh M Babulal; Suzie Chen; Monique M Williams; Jean-Francois Trani; Parul Bakhshi; Grace L Chao; Sarah H Stout; Anne M Fagan; Tammie L S Benzinger; David M Holtzman; John C Morris; Catherine M Roe
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Survey of older drivers' experiences with Florida's mandatory vision re-screening law for licensure.

Authors:  Gerald McGwin; Anne T McCartt; Keli A Braitman; Cynthia Owsley
Journal:  Ophthalmic Epidemiol       Date:  2008 Mar-Apr       Impact factor: 1.648

8.  Driving cessation and health trajectories in older adults.

Authors:  Jerri D Edwards; Melissa Lunsman; Martinique Perkins; George W Rebok; David L Roth
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-08-12       Impact factor: 6.053

9.  Neurologists should endorse active transportation for their patients.

Authors:  Daniel Foster
Journal:  Neurol Clin Pract       Date:  2017-08

10.  Driving status and three-year mortality among community-dwelling older adults.

Authors:  Jerri D Edwards; Martinique Perkins; Lesley A Ross; Sandra L Reynolds
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-30       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.